These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26322949)

  • 21. Detection and quantification of the K103N mutation in HIV reverse transcriptase by pyrosequencing.
    García-González C; García-Bujalance S; Ruiz-Carrascoso G; Arribas JR; González-García J; Bernardino JI; Pascual-Pareja JF; Martínez-Prats L; Delgado R; Mingorance J
    Diagn Microbiol Infect Dis; 2012 Jan; 72(1):90-6. PubMed ID: 22078905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selection and persistence of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapy.
    Palmer S; Boltz V; Maldarelli F; Kearney M; Halvas EK; Rock D; Falloon J; Davey RT; Dewar RL; Metcalf JA; Mellors JW; Coffin JM
    AIDS; 2006 Mar; 20(5):701-10. PubMed ID: 16514300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004.
    Pillay V; Ledwaba J; Hunt G; Rakgotho M; Singh B; Makubalo L; Bennett DE; Puren A; Morris L
    Antivir Ther; 2008; 13 Suppl 2():101-7. PubMed ID: 18575198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in Santos, Brazil.
    de Sa-Filho DJ; Soares Mda S; Candido V; Gagliani LH; Cavaliere E; Diaz RS; Caseiro MM
    AIDS Res Hum Retroviruses; 2008 Mar; 24(3):347-53. PubMed ID: 18327988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy.
    Peuchant O; Thiébaut R; Capdepont S; Lavignolle-Aurillac V; Neau D; Morlat P; Dabis F; Fleury H; Masquelier B;
    AIDS; 2008 Jul; 22(12):1417-23. PubMed ID: 18614864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV type-1 genotypic resistance profiles in vertically infected patients from Argentina reveal an association between K103N+L100I and L74V mutations.
    Aulicino PC; Rocco CA; Mecikovsky D; Bologna R; Mangano A; Sen L
    Antivir Ther; 2010; 15(4):641-50. PubMed ID: 20587857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequencing-based detection of low-frequency human immunodeficiency virus type 1 drug-resistant mutants by an RNA/DNA heteroduplex generator-tracking assay.
    Kapoor A; Jones M; Shafer RW; Rhee SY; Kazanjian P; Delwart EL
    J Virol; 2004 Jul; 78(13):7112-23. PubMed ID: 15194787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of an allele-specific PCR to clinical HIV genotyping samples detects additional K103N mutations in both therapy naïve and experienced patients.
    Carr JM; Green T; Shaw D; Daly L; Hart W; Ratcliff R; Higgins G; Burrell CJ; Li P; Qiao M
    J Med Virol; 2009 Dec; 81(12):1983-90. PubMed ID: 19856473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of DNA sequencing and a line probe assay for detection of human immunodeficiency virus type 1 drug resistance mutations in patients failing highly active antiretroviral therapy.
    Servais J; Lambert C; Fontaine E; Plesséria JM; Robert I; Arendt V; Staub T; Schneider F; Hemmer R; Burtonboy G; Schmit JC
    J Clin Microbiol; 2001 Feb; 39(2):454-9. PubMed ID: 11158089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergence of NNRTI drug resistance mutations after single-dose nevirapine exposure in HIV type 1 subtype C-infected infants in India.
    Kurle SN; Gangakhedkar RR; Sen S; Hayatnagarkar SS; Tripathy SP; Paranjape RS
    AIDS Res Hum Retroviruses; 2007 May; 23(5):682-5. PubMed ID: 17530993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A simple microfluidic assay for the detection of ligation product.
    Zhang L; Wang J; Roebelen J; Tripathi A
    Mol Diagn Ther; 2015 Feb; 19(1):59-64. PubMed ID: 25609550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simple PCR assays improve the sensitivity of HIV-1 subtype B drug resistance testing and allow linking of resistance mutations.
    Johnson JA; Li JF; Wei X; Lipscomb J; Bennett D; Brant A; Cong ME; Spira T; Shafer RW; Heneine W
    PLoS One; 2007 Jul; 2(7):e638. PubMed ID: 17653265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of HIV-1 antiretroviral resistance from patients with persistently low but detectable viraemia.
    Mackie N; Dustan S; McClure MO; Weber JN; Clarke JR
    J Virol Methods; 2004 Aug; 119(2):73-8. PubMed ID: 15158587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid detection of drug resistant HIV -1 to reverse transcriptase and protease inhibitors in HIV-infected patients receiving highly active antiretroviral therapies.
    Yu M; Kabat W; Wang J
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Dec; 14(4):325-9. PubMed ID: 11471017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of drug resistance mutations as a predictor of subsequent virological failure in patients with HIV-1 viral rebounds of less than 1,000 RNA copies/ml.
    Verhofstede C; Van Wanzeele F; Van Der Gucht B; Pelgrom J; Vandekerckhove L; Plum J; Vogelaers D
    J Med Virol; 2007 Sep; 79(9):1254-60. PubMed ID: 17607772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relative replication fitness of efavirenz-resistant mutants of HIV-1: correlation with frequency during clinical therapy and evidence of compensation for the reduced fitness of K103N + L100I by the nucleoside resistance mutation L74V.
    Koval CE; Dykes C; Wang J; Demeter LM
    Virology; 2006 Sep; 353(1):184-92. PubMed ID: 16797050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic evaluation of allele-specific real-time PCR for the detection of minor HIV-1 variants with pol and env resistance mutations.
    Paredes R; Marconi VC; Campbell TB; Kuritzkes DR
    J Virol Methods; 2007 Dec; 146(1-2):136-46. PubMed ID: 17662474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitivity and specificity of the ViroSeq human immunodeficiency virus type 1 (HIV-1) genotyping system for detection of HIV-1 drug resistance mutations by use of an ABI PRISM 3100 genetic analyzer.
    Eshleman SH; Crutcher G; Petrauskene O; Kunstman K; Cunningham SP; Trevino C; Davis C; Kennedy J; Fairman J; Foley B; Kop J
    J Clin Microbiol; 2005 Feb; 43(2):813-7. PubMed ID: 15695685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genotypic analysis of HIV-1 drug resistance at the limit of detection: virus production without evolution in treated adults with undetectable HIV loads.
    Kieffer TL; Finucane MM; Nettles RE; Quinn TC; Broman KW; Ray SC; Persaud D; Siliciano RF
    J Infect Dis; 2004 Apr; 189(8):1452-65. PubMed ID: 15073683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presence of drug resistance mutations among drug-naive patients in Morocco.
    Annaz HE; Recordon-Pinson P; Baba N; Sedrati O; Mrani S; Fleury H
    AIDS Res Hum Retroviruses; 2011 Aug; 27(8):917-20. PubMed ID: 21087198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.